Abstract
Spontaneous hypoglycemia is a puzzling clinical problem and an important reason for referral to endocrinologists. Several clinical conditions such as insulinomas, non-insulinoma pancreatogenous hypoglycemia syndrome, insulin autoimmune syndrome, postprandial hypoglycemia (reactive hypoglycemia), non-islet cell tumor hypoglycemia, primary adrenal insufficiency, hypopituitarism, and critical illness can be associated with spontaneous hypoglycemia. Rarely, in patients with mental health issues, factious hypoglycemia from extrinsic insulin use or ingestion of oral hypoglycemic agents can obfuscate the clinical picture for clinicians trying to identify an organic cause. In those presenting with Whipple’s triad (symptoms ± signs of hypoglycemia, low plasma glucose, and resolution symptoms ± signs after hypoglycemia correction), a 72-h supervised fast test with measurement of plasma insulin, c-peptide, pro-insulin, and beta-hydroxybutyrate levels, coupled with plasma/urine sulphonylurea screen, forms the first step in diagnostic evaluation. A mixed meal test is preferable for those with predominantly postprandial symptoms. Additional non-invasive and/or invasive diagnostic evaluation is necessary if an organic hypoglycemic disorder is suspected. With the aid of a few brief clinical case scenarios, we discuss the diagnostic evaluation and management of spontaneous hypoglycemia through this comprehensive article.



Similar content being viewed by others
References
J.J. Ross, A. Vaidya, U.B. Kaiser, Interactive medical case. Lying low. N. Engl. J. Med. 364, e10 (2011)
A. Vaidya, U.B. Kaiser, B.D. Levy, J Loscalzo, Clinical problem-solving. Lying low. N. Engl. J. Med. 364, 871. Erratum in: N. Engl. J. Med. 364, 1682 (2011)
S. Otake, T. Kikkawa, M. Takizawa et al., Hypoglycemia observed on continuous glucose monitoring associated with IGF-2-producing solitary fibrous tumor. J. Clin. Endocrinol. Metab. 100, 2519–2524 (2015)
P. Martens, J. Tits, Approach to the patient with spontaneous hypoglycemia. Eur. J. Intern. Med. 25, 415–421 (2014)
F. Waldron-Lynch, S.E. Inzucchi, L. Menard et al., Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myeloma. J. Clin. Endocrinol. Metab. 97, 4317–4323 (2012)
P.E. Cryer, L. Axelrod, A.B. Grossman, S.R. Heller, V.M. Montori, E.R. Seaquist, F.J. Service, Endocrine Society, Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 94, 709–728 (2009)
C.L. Ng, Hypoglycaemia in nondiabetic patients—an evidence. Aust. Fam. Phys. 39, 399–404 (2010)
A.O. Whipple, V.K. Frantz, Adenoma of islet cells with hyperinsulinism: a review. Ann. Surg. 101, 1299–1335 (1935)
P.E. Cryer, Glucose homeostasis and hypoglycemia, in Williams Textbook of Endocrinology, 13th edn., ed. by S. Melmed, K.S. Polonsky, P.R. Larsen, H.M. Kronenberg (Elsevier, New York, 2015), pp. 1582–1607
J.M. Guettier, P. Gorden, Hypoglycemia. Endocrinol. Metab. Clin. N. Am. 35, 753–766 (2006)
F.J. Service, Classification of hypoglycemic disorders. Endocrinol. Metab. Clin. N. Am. 28, 501–517 (1999)
P.T. Antonakis, H. Ashrafian, A. Martinez-Isla, Pancreatic insulinomas: laparoscopic management. World J. Gastrointest. Endosc. 7, 1197–1207 (2015)
A. Mehrabi, L. Fischer, M. Hafezi, A. Dirlewanger, L. Grenacher, M.K. Diener et al., A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas 43, 675–686 (2014)
T. Okabayashi, Y. Shima, T. Sumiyoshi, A. Kozuki, S. Ito, Y. Ogawa et al., Diagnosis and management of insulinoma. World J. Gastroenterol. 19, 829–837 (2013)
P. Iglesias, J.J. Díez, Management of endocrine disease: a clinical update on tumor-induced hypoglycemia. Eur. J. Endocrinol. 170, R147–R157 (2014)
K.A. Placzkowski, A. Vella, G.B. Thompson, C.S. Grant, C.C. Reading, J.W. Charboneau et al., Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J. Clin. Endocrinol. Metab. 94, 1069–1073 (2009)
K. Oberg, B. Eriksson, Endocrine tumours of the pancreas. Best Pract. Res. Clin. Gastroenterol. 19, 753–781 (2005)
A.M. Dizon, S. Kowalyk, B.J. Hoogwerf, Neuroglycopenic and other symptoms in patients with insulinomas. Am. J. Med. 106, 307–310 (1999)
A. Starke, C. Saddig, L. Mansfeld et al., Malignant metastatic insulinoma-postoperative treatment and follow-up. World J. Surg. 29, 789–793 (2005)
K. Suzuki, A. Kawasaki, M. Miyamoto, T. Miyamoto, T. Kanbayashi, M. Sato et al., Insulinoma masquerading as rapid eye movement sleep behavior disorder: case series and literature review. Medicine (Baltimore) 94, e1065 (2015)
M. Quinkler, F. Strelow, M. Pirlich, W. Rohde, H. Biering, H. Lochs et al., Assessment of suspected insulinoma by 48-hour fasting test: a retrospective monocentric study of 23 cases. Horm. Metab. Res. 39, 507–510 (2007)
B. Hirshberg, A. Livi, D.L. Bartlett, S.K. Libutti, H.R. Alexander, J.L. Doppman et al., Forty-eight-hour fast: the diagnostic test for insulinoma. J. Clin. Endocrinol. Metab. 85, 3222–3226 (2000)
R.T. Jensen, G. Cadiot, M.L. Brandi, W.W. de Herder, G. Kaltsas, P. Komminoth et al., ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 95, 98–119 (2012)
D. Vezzosi, A. Bennet, J. Fauvel, P. Caron, Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur. J. Endocrinol. 157, 75–83 (2007)
D.D. De León, C.A. Stanley, Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia. Best Pract. Res. Clin. Endocrinol. Metab. 27, 763–769 (2013)
E. Christ, D. Wild, S. Ederer, M. Béhé, G. Nicolas, M.E. Caplin et al., Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol. 1(2), 115–122 (2013)
R. Padidela, M. Fiest, V. Arya, V.V. Smith, M. Ashworth, D. Rampling et al., Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients. Eur. J. Endocrinol. 170, 741–747 (2014)
A.J. Joseph, N. Kapoor, E.G. Simon, A. Chacko, E.M. Thomas, A. Eapen et al., Endoscopic ultrasonography–a sensitive tool in the preoperative localization of insulinoma. Endocr. Pract. 19, 602–608 (2013)
J. Morera, A. Guillaume, P. Courtheoux, L. Palazzo, A. Rod, M. Joubert, Y. Reznik, Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance. J. Endocrinol. Invest. (2015). doi:10.1007/s40618-015-0406-4
J.K. Law, V.K. Singh, M.A. Khashab, R.H. Hruban, M.I. Canto, E.J. Shin et al., Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery. Surg. Endosc. 27, 3921–3926 (2013)
P. Iglesias, C. Lafuente, M.Á. Martín Almendra, A. López Guzmán, J.C. Castro, J.J. Díez, Insulinoma: a multicenter, retrospective analysis of three decades of experience (1983-2014). Endocrinol. Nutr. 62, 306–313 (2015)
X.M. Keutgen, N. Nilubol, E. Kebebew, Malignant-functioning neuroendocrine tumors of the pancreas: a survival analysis. Surgery (2015). doi:10.1016/j.surg.2015.11.010
M.H. Kulke, E.K. Bergsland, J.C. Yao, Glycemic control in patients with insulinoma treated with everolimus. N. Engl. J. Med. 360, 195–197 (2009)
N. Thomas, A. Brooke, G. Besser, Long-term maintenance of normoglycaemia using everolimus in a patient with disseminated insulinoma and severe hypoglycaemia. Clin. Endocrinol. (Oxf). 78, 799–800 (2013)
P.M. Thomas, G.J. Cote, N. Wohllk, B. Haddad, P.M. Mathew, W. Rabl et al., Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycaemia of infancy. Science 268, 426–429 (1995)
A. Nestorowicz, N. Inagaki, T. Gonoi, K.P. Schoor, B.A. Wilson, B. Glaser et al., A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 46, 1743–1748 (1997)
D. Ouyang, D. Dhall, R. Yu, Pathologic pancreatic endocrine cell hyperplasia. World J. Gastroenterol. 17, 137–143 (2011)
K.M. Rumilla, L.A. Erickson, F.J. Service, A. Vella, G.B. Thompson, C.S. Grant et al., Hyperinsulinemic hypoglycaemia with nesidioblastosis: histologic features and growth factor expression. Mod. Pathol. 22, 239–245 (2009)
K.A. Vanderveen, C.S. Grant, G.B. Thompson, D.R. Farley, M.L. Richards, A. Vella et al., Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycaemia from diffuse islet cell disease. Surgery. 148, 1237–1245 (2010)
T. Mala, Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment. Surg. Obes. Relat. Dis. 10, 1220–1225 (2014)
C. Then, Y.C. Nam-Apostolopoulos, J. Seissler, A. Lechner, Refractory idiopathic non-insulinoma pancreatogenous hypoglycemia in an adult: case report and review of the literature. JOP. 14, 264–268 (2013)
P. Ritz, C. Vaurs, M. Barigou, H. Hanaire, Hypoglycaemia following gastric bypass: mechanisms and treatment. Diabetes Obes. Metab. (2015). doi:10.1111/dom.12592
C.Y. Woo, J.Y. Jeong, J.E. Jang, J. Leem, C.H. Jung, E.H. Koh et al., Clinical features and causes of endogenous hyperinsulinemic hypoglycemia in Korea. Diabetes Metab. J. 39, 126–131 (2015)
M. Anlauf, D. Wieben, A. Perren, B. Sipos, P. Komminoth, A. Raffel et al., Persistent hyperinsulinemic hypoglycaemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am. J. Surg. Pathol. 29, 524–533 (2005)
R. Pathak, P. Karmacharya, A. Salman, R. Alweis, An unusual cause of hypoglycemia in a middle-aged female after bariatric surgery. J. Community Hosp. Intern. Med. Perspect. 4, 23118 (2014). doi:10.3402/jchimp.v4.23118
S.M. Thompson, A. Vella, G.B. Thompson, K.M. Rumilla, F.J. Service, C.S. Grant, J.C. Andrews, Selective arterial calcium stimulation with hepatic venous sampling differentiates insulinoma from nesidioblastosis. J. Clin. Endocrinol. Metab. 100, 4189–4197 (2015)
E. Christ, D. Wild, K. Antwi, B. Waser, M. Fani, S. Schwanda et al., Preoperative localization of adult nesidioblastosis using (68)Ga-DOTA-exendin-4-PET/CT. Endocrine 50, 821–823 (2015)
I. Dravecka, I. Lazurova, Nesidioblastosis in adults. Neoplasma 61, 252–256 (2014)
Y.L. Wang, P.W. Yao, X.T. Zhang, Z.Z. Luo, P.Q. Wu, F. Xiao, Insulin autoimmune syndrome: 73 cases of clinical analysis. Chin. Med. J. (Engl). 128, 2408–2409 (2015)
S.L. Wong, A. Priestman, D.T. Holmes, Recurrent hypoglycemia from insulin autoimmune syndrome. J. Gen. Intern. Med. 29, 250–254 (2014)
Y. Uchigata, Y. Hirata. Insulin autoimmune syndrome (IAS, Hirata disease), in Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity ed. by Eisenbarth G.S., 1 edn (Landes Company, Paris, 1999) pp. 245–253
E.S. Paiva, A.E. Pereira, M.T. Lombardi et al., Insulin autoimmune syndrome (Hirata disease) as differential diagnosis in patients with hyperinsulinemic hypoglycemia. Pancreas 32, 431–432 (2006)
J.B. Redmon, F.Q. Nuttall, Autoimmune hypoglycemia. Endocrinol. Metab. Clin. N. Am. 28, 603–618, vii (1999)
B.C. Lupsa, A.Y. Chong, E.K. Cochran, M.A. Soos, R.K. Semple, P. Gorden, Autoimmune forms of hypoglycemia. Medicine (Baltimore) 88, 141–153 (2009)
R. Kefurt, F.B. Langer, K. Schindler, S. Shakeri-Leidenmühler, B. Ludvik, G. Prager, Hypoglycemia after Roux-En-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test. Surg. Obes. Relat. Dis. 11, 564–569 (2015)
T.W. Bodnar, M.J. Acevedo, M. Pietropaolo, Management of non-islet-cell tumor hypoglycemia: a clinical review. J. Clin. Endocrinol. Metab. 99, 713–722 (2014)
Y. Dynkevich, K.I. Rother, I. Whitford et al., Tumors, IGF-2 and hypoglycemia: insights from the clinic, the laboratory and the historical archive. Endocr. Rev. 34, 798–826 (2013)
I. Fukuda, N. Hizuka, Y. Ishikawa, K. Yasumoto, Y. Murakami, A. Sata et al., Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm. IGF Res. 16, 211–216 (2006)
S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer et al., Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 101(2), 364–389 (2016)
J.J. Christiansen, C.B. Djurhuus, C.H. Gravholt, P. Iversen, J.S. Christiansen, O. Schmitz et al., Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. J. Clin. Endocrinol. Metab. 92, 3553–3559 (2007)
S. Hsieh, P.C. White, Presentation of primary adrenal insufficiency in childhood. J. Clin. Endocrinol. Metab. 96, E925–E928 (2011)
A. Pia, A. Piovesan, F. Tassone, P. Razzore, G. Visconti, G. Magro et al., A rare case of adulthood-onset growth hormone deficiency presenting as sporadic, symptomatic hypoglycemia. J. Endocrinol. Invest. 27, 1060–1064 (2004)
M. Takai, H. Kaneto, S. Kamei, T. Mune, K. Kaku, A case of hypothalamic hypopituitarism accompanied by recurrent severe hypoglycaemia. Springerplus 4, 173 (2015). doi:10.1186/s40064-015-0934-6
T.D. Bhutia, R. Lodha, S.K. Kabra, Abnormalities in glucose homeostasis in critically ill children. Pediatr. Crit. Care Med. 14, e16–e25 (2013)
S. Finfer, Hypoglycemia in critically ill adults—association yes, causation not proven. Crit. Care 15, 1012 (2011)
Funding
No funding received for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Nothing to declare.
Rights and permissions
About this article
Cite this article
Kandaswamy, L., Raghavan, R. & Pappachan, J.M. Spontaneous hypoglycemia: diagnostic evaluation and management. Endocrine 53, 47–57 (2016). https://doi.org/10.1007/s12020-016-0902-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-0902-0